Treatment of Non-Tuberculous Mycobacterial Infections With Interferon Gamma

计划入组 60 人 · 首次发布于 2002 年 12 月 10 日

Toxicity of Treatments for Non-tuberculous Mycobacterial Infections in Cancer Patients or Not

计划入组 41 人 · 首次发布于 2021 年 9 月 1 日

A Prospective Registry For Non Tuberculous Mycobacterial (NTM) Infections

计划入组 200 人 · 首次发布于 2015 年 2 月 4 日

non-tuberculosis mycobacterial diseases/ tuberculosis therapy

Mycobacterial tolerance inhibitors (tuberculosis)

Undisclosed program (mycobacterial infection)

The Cooper Health System, A New Jersey Non-Profit Corporation

United States

REPLIGEN CORPORATION

United States

EMCURE PHARMACEUTICALS LIMITED

United Arab Emirates

MicuRx Receives FDA Clearance to Advance MRX-5 into Phase 2a Trial for Mycobacterium abscessus Pulmonary Disease

Spero Therapeutics Initiates Phase 3 Trial for First Oral Carbapenem in US, Targeting Complicated UTIs

BioVersys Partners with Hackensack Meridian Health to Advance Novel Ansamycin Antibiotics for Non-Tuberculous Mycobacteria